These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 14645912

  • 21. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
    Pega J, Di Giacomo S, Bucafusco D, Schammas JM, Malacari D, Barrionuevo F, Capozzo AV, Rodríguez LL, Borca MV, Pérez-Filgueira M.
    J Virol; 2015 Sep; 89(18):9581-90. PubMed ID: 26157128
    [Abstract] [Full Text] [Related]

  • 22. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M, Lohse L, Bøtner A, McInerney GM, Burman A, Jackson T, Polacek C, Belsham GJ.
    PLoS One; 2016 Sep; 11(6):e0157435. PubMed ID: 27294397
    [Abstract] [Full Text] [Related]

  • 23. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ.
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [Abstract] [Full Text] [Related]

  • 24. Single immunization with a recombinant multiple-epitope protein induced protection against FMDV type Asia 1 in cattle.
    Fang M, Wang H, Tang T, Zhao P, Du J, Guo S, Wei H, Xu H, Wan M, Wei X, Yu Y, Wang L.
    Int Immunopharmacol; 2015 Oct; 28(2):960-6. PubMed ID: 26365702
    [Abstract] [Full Text] [Related]

  • 25. Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.
    Cubillos C, de la Torre BG, Bárcena J, Andreu D, Sobrino F, Blanco E.
    Virol J; 2012 Mar 14; 9():66. PubMed ID: 22416886
    [Abstract] [Full Text] [Related]

  • 26. The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes.
    Grant CFJ, Carr BV, Kotecha A, van den Born E, Stuart DI, Hammond JA, Charleston B.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228594
    [Abstract] [Full Text] [Related]

  • 27. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q.
    J Virol Methods; 2006 Sep 01; 136(1-2):230-7. PubMed ID: 16780963
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S, Brito BP, Perez AM, Bucafusco D, Pega J, Rodríguez L, Borca MV, Pérez-Filgueira M.
    Transbound Emerg Dis; 2015 Jun 01; 62(3):280-7. PubMed ID: 23895140
    [Abstract] [Full Text] [Related]

  • 29. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL, Paton DJ, Rieder E, Barnett PV.
    Vaccine; 2008 Apr 07; 26(16):1982-9. PubMed ID: 18342409
    [Abstract] [Full Text] [Related]

  • 30. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.
    Eschbaumer M, Stenfeldt C, Rekant SI, Pacheco JM, Hartwig EJ, Smoliga GR, Kenney MA, Golde WT, Rodriguez LL, Arzt J.
    BMC Vet Res; 2016 Sep 15; 12():205. PubMed ID: 27634113
    [Abstract] [Full Text] [Related]

  • 31. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M, Ningyi J, Juan LH, Min Z, Guoshun S, Guangze Z, Huijun L, Xiaowei H, Minglan J, Xu L, Haili M, Yue J, Gefen Y, Kuoshi J.
    Antiviral Res; 2007 Oct 15; 76(1):59-67. PubMed ID: 17606304
    [Abstract] [Full Text] [Related]

  • 32. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-Mahecha OL, Mansilla FC, Pérez-Filgueira DM, Grigera PR.
    Antiviral Res; 2011 Nov 15; 92(2):219-27. PubMed ID: 21889542
    [Abstract] [Full Text] [Related]

  • 33. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF, Nsamba P, Mutowembwa P, Rotherham LS, Esterhuysen J, Scott K.
    Vaccine; 2015 Jun 09; 33(25):2909-16. PubMed ID: 25930116
    [Abstract] [Full Text] [Related]

  • 34. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
    Tang H, Liu X, Fang Y, Jiang S, Pan L, Lv J, Zhang Z, Zhou P, Zhang Y, Wang Y.
    Wei Sheng Wu Xue Bao; 2013 Jun 04; 53(6):596-607. PubMed ID: 24028062
    [Abstract] [Full Text] [Related]

  • 35. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X, Liu R, Tang H, Jin M, Chen H, Qian P.
    Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351
    [Abstract] [Full Text] [Related]

  • 36. Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide.
    Blanco E, Guerra B, de la Torre BG, Defaus S, Dekker A, Andreu D, Sobrino F.
    Antiviral Res; 2016 May 23; 129():74-80. PubMed ID: 26956030
    [Abstract] [Full Text] [Related]

  • 37. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
    Lei Y, Shao J, Ma F, Lei C, Chang H, Zhang Y.
    Mol Immunol; 2020 May 23; 121():118-126. PubMed ID: 32199211
    [Abstract] [Full Text] [Related]

  • 38. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR, Zhou X, Lefebvre DJ, Garnier A, Watier F, Pignon C, Lacour SA, Zientara S, Bakkali-Kassimi L, De Clercq K, Klonjkowski B.
    Vaccine; 2018 Apr 12; 36(16):2193-2198. PubMed ID: 29544690
    [Abstract] [Full Text] [Related]

  • 39. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y, Shao J, Zhao F, Li Y, Lei C, Ma F, Chang H, Zhang Y.
    J Med Virol; 2019 Dec 12; 91(12):2142-2152. PubMed ID: 31347713
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R, Brake DA, Barrera J, Schutta CJ, Kalla M, Wennier ST, Volkmann A, Hurtle W, Clark BA, Zurita M, Pisano M, Kamicker BJ, Puckette MC, Rasmussen MV, Neilan JG.
    Vaccine; 2020 Jan 22; 38(4):769-778. PubMed ID: 31718901
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.